Table 2.
Investigator | Setting | Implementation Framework | Study Design | Intervention | Clinical Outcomes (Examples) | Implementation Outcomes (Examples) | Implementation Issues |
---|---|---|---|---|---|---|---|
M. Schatz | Kaiser Permanente, outpatient asthma care | PEPFAR’s impact evaluation | Randomized controlled trial | Referral to asthma specialist for high rescue medication users | Rescue medication use | Adoption | Engaging primary care and specialist providers |
Specialist consultation | Feasibility | ||||||
Exacerbations | Penetration | ||||||
C. Thomson | Teaching, hospital ICUs | PARIHS | Pre–post intervention | Modify practice standard in critical care units (e.g., targeted temperature management post-MI) | Survival | Acceptability | Lack of awareness of evidence and urgency to change |
Neurologic status | Adoption | Engaging multiple specialties and disciplines | |||||
Appropriateness | Integrating changes into workflow | ||||||
Feasibility | |||||||
Sustainability | |||||||
S. Wilson, H Tapp | Multiple primary care practices | RE-AIM | Pre–post intervention | Shared asthma treatment decision making intervention tailored to practice needs | Hospitalizations and emergency department visits for asthma | Adoption by practices, providers and patients | Competing demands from health care system |
Sustainability of the intervention | Obtaining frank stakeholder feedback on process | ||||||
Practice staff turnover | |||||||
K. Riekert | Cystic fibrosis outpatient clinics | CFIR | Cluster (clinic level) randomized controlled trial | Comprehensive adherence program | Medication adherence | Adoption | Providers’ resistance to change |
Health-related quality of life | Feasibility | Clinical team turnover | |||||
Subject’s knowledge and skills | Fidelity | Access to pharmacy refill reporting (for adherence measurement) | |||||
Sustainability | |||||||
B. Bender | Kaiser Permanente outpatient clinics | RE-AIM | Pragmatic controlled trial | Patient reminders via interactive voice recognition and EHR | Inhaled corticosteroid use | Acceptability | Research team turnover |
Fidelity | Integrating intervention into existing EHR | ||||||
C. Rand | Head Start programs | RE-AIM | Randomized, controlled trial | Motivational interviewing to reduce secondhand smoke exposure in children | Secondhand smoke exposure | Acceptability | Staff safety when conducting home visits |
Healthcare utilization | Adoption | Competing demands of community partners and families | |||||
Caregiver beliefs | Sustainability | ||||||
Head Start staff beliefs | |||||||
M. Cloutier | Primary care practices | RE-AIM | Pre–post intervention with contemporaneous control group | Primary care provider training on asthma guidelines | Adherence to inhaled corticosteroid use and treatment plan distribution | Adoption | Incompatible EHR systems |
Hospital, emergency department, and urgent care outpatient utilization | Sustainability | Specialists’ concerns about “turf” | |||||
J. Krishnan, J. Gerald | Minority serving hospital | Not applicable* | Pragmatic controlled trial | Community health worker and phone- based peer coaches for hospitalized patients | Patient experience (e.g., satisfaction, anxiety, social support, physical and mental health) | Acceptability | Engaging institutional leadership |
Hospital readmission | Appropriateness | Identifying opportunities to collaborate with other quality improvement programs intended to reduce hospital readmissions | |||||
Fidelity | |||||||
Cost |
Definition of abbreviations: CFIR = Consolidated Framework for Implementation Research; EHR = electronic health record; ICU = intensive care unit; MI = myocardial infarction; PARIHS = Promoting Action on Research Implementation in Health Services; PEPFAR = President’s Emergency Plan for AIDS Relief; RE-AIM = Reach, Effectiveness, Adoption, Implementation, Maintenance.
Study design included effectiveness and IR elements. The latter component focused on budget impact analysis.